Chris Brawley

4.7k total citations · 1 hit paper
11 papers, 301 citations indexed

About

Chris Brawley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chris Brawley has authored 11 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chris Brawley's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Bone health and treatments (2 papers). Chris Brawley is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Bone health and treatments (2 papers). Chris Brawley collaborates with scholars based in United Kingdom, United States and Australia. Chris Brawley's co-authors include Mahesh Parmar, Matthew R. Sydes, Adrian Cook, Christopher Parker, Chris Brown, Silvia Forcat, Pierre Richaud, Jayne F. Tierney, Meryem Brihoum and Paul Sargos and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Chris Brawley

10 papers receiving 297 citations

Hit Papers

Adjuvant or early salvage radiotherapy for the treatment ... 2020 2026 2022 2024 2020 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
    2020 185 citations Claire L. Vale, David J. Fisher et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Brawley United Kingdom 5 265 71 52 51 39 11 301
María Ángeles Cabeza Rodríguez Spain 6 290 1.1× 39 0.5× 98 1.9× 40 0.8× 38 1.0× 11 318
Marlon Silva France 8 384 1.4× 87 1.2× 113 2.2× 55 1.1× 28 0.7× 16 412
Carmen González San Segundo Spain 6 265 1.0× 34 0.5× 87 1.7× 27 0.5× 24 0.6× 26 288
Rudi Ross United States 11 253 1.0× 67 0.9× 112 2.2× 43 0.8× 47 1.2× 21 330
Kenneth L. Zeitzer United States 10 255 1.0× 32 0.5× 49 0.9× 42 0.8× 29 0.7× 22 297
M. L. Vázquez de la Torre Spain 6 266 1.0× 29 0.4× 92 1.8× 26 0.5× 22 0.6× 12 283
A. Guerrero Spain 5 263 1.0× 28 0.4× 91 1.8× 25 0.5× 18 0.5× 16 279
Andrea Hiltz Canada 3 362 1.4× 31 0.4× 68 1.3× 39 0.8× 88 2.3× 4 407
Rédouane Bettahar Canada 7 201 0.8× 23 0.3× 90 1.7× 86 1.7× 35 0.9× 16 275
Lennart Åström Sweden 9 247 0.9× 34 0.5× 119 2.3× 32 0.6× 23 0.6× 20 294

Countries citing papers authored by Chris Brawley

Since Specialization
Citations

This map shows the geographic impact of Chris Brawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Brawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Brawley more than expected).

Fields of papers citing papers by Chris Brawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Brawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Brawley. The network helps show where Chris Brawley may publish in the future.

Co-authorship network of co-authors of Chris Brawley

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Brawley. A scholar is included among the top collaborators of Chris Brawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Brawley. Chris Brawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Usmani, Saad Z., Michał Mielnik, Mamta Garg, et al.. (2024). Phase I Study of Belantamab Mafodotin in Combination with Standard of Care in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Dreamm-9 Updated Interim Analysis. Blood. 144(Supplement 1). 497–497. 3 indexed citations
2.
3.
4.
Ali, Adnan, Alex Hoyle, Áine Haran, et al.. (2021). Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer. JAMA Oncology. 7(4). 555–555. 74 indexed citations
5.
Haran, Áine, Adnan Ali, Alex Hoyle, et al.. (2020). 634P Impact of metastatic lymph node burden on survival in patients with mHSPC from the "docetaxel comparison” of the STAMPEDE trial. Annals of Oncology. 31. S522–S523. 2 indexed citations
6.
7.
Vale, Claire L., David J. Fisher, Andrew Kneebone, et al.. (2020). Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. The Lancet. 396(10260). 1422–1431. 185 indexed citations breakdown →
8.
Rush, Hannah, Adrian Cook, Chris Brawley, et al.. (2020). Comparative quality of life in patients randomized contemporaneously to docetaxel or abiraterone in the STAMPEDE trial.. Journal of Clinical Oncology. 38(6_suppl). 14–14. 14 indexed citations
9.
Clarke, Caroline S., Chris Brawley, Fiona C. Ingleby, et al.. (2020). Addition of abiraterone to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Model to estimate long-term survival, quality-adjusted survival, and cost-effectiveness.. Journal of Clinical Oncology. 38(6_suppl). 204–204.
10.
11.
Parker, Chris, Nicholas D. James, Chris Brawley, et al.. (2018). Radiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE. Annals of Oncology. 29. viii722–viii723. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Ángeles Cabeza Rodríguez Breakdown of academic impact, for papers by Marlon Silva Breakdown of academic impact, for papers by Carmen González San Segundo Breakdown of academic impact, for papers by Rudi Ross Breakdown of academic impact, for papers by Kenneth L. Zeitzer Breakdown of academic impact, for papers by M. L. Vázquez de la Torre Breakdown of academic impact, for papers by A. Guerrero Breakdown of academic impact, for papers by Andrea Hiltz Breakdown of academic impact, for papers by Rédouane Bettahar Breakdown of academic impact, for papers by Lennart Åström
Rankless by CCL
2026